Entrepreneurial Spirit, Rooted in Tradition. At Mitsubishi Tanabe Pharma America, Inc. (MTPA), we can tout a storied reputation more than 300 years in the making. Our parent company, Mitsubishi Tanabe Pharma Corporation, is a research-driven pharmaceutical company with global reach – and one of Japan’s oldest and most respected companies.
With the recent FDA approval and availability in the U.S. of RADICAVA® (edaravone) MTPA is rapidly expanding our operation across all functional areas to launch this new product in the U.S. market. Concurrently, the company is expanding its research efforts and exploring collaborations with partners to discover and bring treatments to market for unmet medical needs including orphan diseases. We currently seek motivated professionals who share our vision of scientific excellence, innovation, and unwavering dedication to improving the lives of patients.
The Director, Corporate Accounts, will build the payer team and focus on strategy to support the launch and life cycle management of our lead ALS therapy and future products in the United States. The incumbent will work closely with other members of the commercial team, including marketing, sales, trade, and sales operations, as well as other cross-functional partners.
The Director, Corporate Accounts will be responsible for developing a corporate account team and executing an annual plan to achieve priorities for engagement with key external groups: Commercial Payers, Medicare Advantage plans, PBM’s commercial and Part D, FFS Medicaid, Managed Medicaid plans and potential MAC and Tri Care involvement. Incumbent will work closely with Commercial, Medical, R&D and other functions to ensure that priorities and investments with external stakeholders align with overarching business goals, and also manage a budget to accomplish objectives.